These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Stocks in Asia traded lower on Monday morning, as investors await the start of a Nasdaq-style technology board on the Shanghai Stock Exchange.Asia Marketsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
Gluskin Sheff's David Rosenberg is painting a painful picture for stocks as earnings season goes into full gear.Futures Nowread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Weather & Natural Disastersread more
General Electric CEO Larry Culp's latest comments to CNBC about GE Healthcare could indicate an "outright sale" is among the options under consideration, according to a leading industry analyst.
Culp called GE Healthcare a "tremendous" franchise, which has "flexibility" in terms of the planned spinoff. "We could preserve our tax-free spin status while selling up to 49.9 percent," Culp told CNBC's David Faber on Monday.
"I think [Culp] is weighing all options including the outright sale of the business or parts of it," Scott Davis, chairman and CEO of Melius Research, told CNBC. Davis, who personally owns GE shares, maintains a buy rating on the stock with a $21 per share price target.
Danaher, where Culp was CEO from 2000 to 2014, would "love" to own the life sciences business of GE Healthcare, Davis added. "As for the diagnostic equipment, that is less clear," he said, stressing it would be "a very large deal."
When asked for further comment, GE directed CNBC to Culp's comments earlier. On the Oct. 30 postearnings call, Culp indicated flexibility around GE Healthcare.
GE Healthcare is a cash cow, throwing off $3.4 billion in profit last year. The unit accounted for 15.8 percent of General Electric's total 2017 sales and contributed 43.2 percent to GE's operating profit last year.
Shortly after the leadership change, both GE and GE Healthcare had told CNBC they were "committed to establishing Healthcare as a separate independent entity."
A spokeswoman for GE Healthcare said at the time that the unit "plans to continue working toward separation," and Flannery's departure "does not change what's happening."
GE Healthcare, under CEO Kieran Murphy, plans to become independent by the end of 2019. General Electric has said the spinoff makes sense because it allows the company to double down on its core industrial and energy businesses.
Shares of GE were under more pressure on Monday, trading around $8 per share around midday. GE is on pace for its worst year since 2008 when it lost 56.3 percent.